Apocrine mixed tumors of the skin with architectural and/or cytologic atypia: A retrospective clinicopathologic study of 18 cases

American Journal of Surgical Pathology

Volumn 31, Issue 7, 2007, Pages 1094-1102

  Kazakov, Dmitry V ^a   Bisceglia, Michele ^b   Spagnolo, Dominic V ^c   Kutzner, Heinz ^d   Belousova, Irena E ^e   Hes, Ondrej ^a   Sima, Radek ^a   Vanecek, Tomas ^a   Yang, Yu ^f   Michal, Michal ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^c PATHWEST LABORATORY MEDICINE   (Australia)

^d Dermatopathologische Gemeinschaftspraxis   (Germany)

^e Medical Military Academy   (Russian Federation)

^f PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Apocrine mixed tumor; Chondroid syringoma; HER 2 neu; Hyaline cell; Malignant mixed tumor; Pleomorphic adenoma; Polysomy 17; Skin adnexal tumors

Indexed keywords

HYALIN; KI 67 ANTIGEN;

ADOLESCENT; ADULT; AGED; APOCRINE GLAND; ARTICLE; CANCER RECURRENCE; CANCER SURGERY; CELL DIFFERENTIATION; CELL INFILTRATION; CELL ULTRASTRUCTURE; CHILD; COLORIMETRY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; GENE AMPLIFICATION; GIANT CELL; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MALE; METASTASIS; MICROSCOPY; MIXED TUMOR; MYOEPITHELIUM CELL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SKIN STRUCTURE; TUMOR LOCALIZATION;

ADULT; AGED; APOCRINE GLANDS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, COMPLEX AND MIXED; RETROSPECTIVE STUDIES; SWEAT GLAND NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 34347339529     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3180309e4d     Document Type: Article

References (33)

1. Banerjee SS, Harris M, Eyden BP, et al. Chondroid syringoma with hyaline cell change. Histopathology. 1993;22:235-245.
2. Bates AW, Baithun SI. Atypical mixed tumor of the skin: histologic, immunohistochemical, and ultrastructural features in three cases and a review of the criteria for malignancy. Am J Dermatopathol. 1998;20:35-40.
3. Bisceglia M, Clemente CR, Vairo M, et al. "Hyaline-cell chondroid syringoma." Morphological, immunohistochemical and ultrastructural study of a case and review of the literature. Pathologica. 1997;89:540-545.
4. Bisceglia M, Cardone M, Fantasia L, et al. Mixed tumors, myoepitheliomas, and oncocytomas of the soft tissues are likely members of the same family: a clinicopathologic and ultrastructural study. Ultrastruct Pathol. 2001;25:399-418.
5. Bisceglia M, Fisher C, Suster S, et al. Tumoral, quasitumoral and pseudotumoral lesions of the superficial and somatic soft tissue: new entities and new variants of old entities recorded during the last 25 years. Part IX: excerpta VII. Pathologica. 2005;97:343-360.
6. Di Palma S, Guzzo M. Myoepithelial carcinoma with predominance of plasmacytoid cells arising in a pleomorphic adenoma of the parotid gland. Histopathology. 1998;33:485.
7. Di Palma S, Skalova A, Vanieek T, et al. Non-invasive (intracapsular) carcinoma ex pleomorphic adenoma: recognition of focal carcinoma by HER-2/neu and MIB1 immunohistochemistry. Histopathology. 2005;46:144-152.
8. Di Palma S, Lambros MB, Savage K, et al. Oncocytic change in pleomorphic adenoma: molecular evidence in support of an origin in neoplastic cells. J Clin Pathol. 2006. [Epub ahead of print.]
9. Downs-Kelly E, Yoder BJ, Stoler M, et al. The influence of polysomy 17 on HER2 gene and protein expression in adenocarcinoma of the breast: a fluorescent in situ hybridization, immunohistochemical, and isotopic mRNA in situ hybridization study. Am J Surg Pathol. 2005;29:1221-1227.
10. Ferreiro JA, Nascimento AG. Hyaline-cell rich chondroid syringoma. A tumor mimicking malignancy. Am J Surg Pathol. 1995;19:912-917.
11. Freitas LL, Araujo VC, Martins MT, et al. Biomarker analysis in carcinoma ex pleomorphic adenoma at an early phase of carcinomatous transformation. Int J Surg Pathol. 2005;13:337-342.
12. Hornick JL, Fletcher CD. Myoepithelial tumors of soft tissue: a clinicopathologic and immunohistochemical study of 101 cases with evaluation of prognostic parameters. Am J Surg Pathol. 2003;27:1183-1196.
13. Jones EC, Clement PB, Young RH. Sclerosing adenosis of the prostate gland. A clinicopathological and immunohistochemical study of 11 cases. Am J Surg Pathol. 1991;15:1171-1180.
14. Kazakov DV, Michal M. Trichoepithelioma with giant and multi-nucleated neoplastic epithelial cells. Am J Dermatopathol. 2006;28:63-64.
15. Kilpatrick SE, Hitchcock MG, Kraus MD, et al. Mixed tumors and myoepitheliomas of soft tissue: a clinicopathologic study of 19 cases with a unifying concept. Am J Surg Pathol. 1997;21:13-22.
16. Kutzner H, Mentzel T, Kaddu S, et al. Cutaneous myoepithelioma: an under-recognized cutaneous neoplasm composed of myoepithelial cells. Am J Surg Pathol. 2001;25:348-355.
17. Lal P, Salazar PA, Ladanyi M, et al. Impact of polysomy 17 on HER-2/neu immunohistochemistry in breast carcinomas without HER-2/neu gene amplification. J Mol Diagn. 2003;5:155-159.
18. LeBoit PE, Burg G, Weedon D, et al. World Health Organization Classification of Tumours. Pathology and Genetics of Skin Tumours. Lyon: IARC Press; 2006.
19. Lewis JE, Olsen KD, Sebo TJ. Carcinoma ex pleomorphic adenoma: pathologic analysis of 73 cases. Hum Pathol. 2001;32:596-604.
20. LiVolsi VA, Perzin KH. Malignant mixed tumors arising in salivary glands. I. Carcinomas arising in benign mixed tumors: a clinicopathologic study. Cancer. 1977;39:2209-2230.
21. Mentzel T, Requena L, Kaddu S, et al. Cutaneous myoepithelial neoplasms: clinicopathologic and immunohistochemical study of 20 cases suggesting a continuous spectrum ranging from benign mixed tumor of the skin to cutaneous myoepithelioma and myoepithelial carcinoma. J Cutan Pathol. 2003;30:294-302.
22. Michal M, Miettinen M. Myoepitheliomas of the skin and soft tissues. Report of 12 cases. Virchows Arch. 1999;434:393-400.
23. Nakayama H, Kishi A, Kajihara H. Hyaline cell-rich chondroid syringoma: epithelial nature of the hyaline cells. Jpn J Clin Oncol. 1996;26:237-242.
24. Popescu NC, King CR, Kraus MH. Localization of the human erbB-2 gene on normal and rearranged chromosomes 17 to bands q12-21.32. Genomics. 1989;4:362-366.
25. Requena L, Kiryu H, Ackerman AB. Neoplasms with apocrine differentiation. Philadelphia: Lippincott-Raven; 1998.
26. Sciubba JJ, Brannon RB. Myoepithelioma of salivary glands: report of 23 cases. Cancer. 1982;49:562-572.
27. Simpson RH, Prasad AR, Lewis JE, et al. Mucin-rich variant of salivary duct carcinoma: a clinicopathologic and immunohistochemical study of four cases. Am J Surg Pathol. 2003;27:1070-1079.
28. Skalova A, Michal M, Ryska A, et al. Oncocytic myoepithelioma and pleomorphic adenoma of the salivary glands. Virchows Arch. 1999;434:537-546.
29. Skalova A, Starek I, Vanecek T, et al. Expression of HER-2/neu gene and protein in salivary duct carcinomas of parotid gland as revealed by fluorescence in-situ hybridization and immunohistochemistry. Histopathology. 2003;42:348-356.
30. Slamon DJ, Godolphin W, Jones LA, et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science. 1989;244:707-712.
31. Takeda Y. An immunohistochemical study of bizarre neoplastic cells in pleomorphic adenoma: its cytological nature and proliferative activity. Pathol Int. 1999;49:993-999.
32. Tortoledo ME, Luna MA, Batsakis JG. Carcinomas ex pleomorphic adenoma and malignant mixed tumors. Histomorphologic indexes. Arch Otolaryngol. 1984;110:172-176.
33. Varshney D, Zhou YY, Geller SA, et al. Determination of HER-2 status and chromosome 17 polysomy in breast carcinomas comparing HercepTest and PathVysion FISH assay. Am J Clin Pathol. 2004;121:70-77.